The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-[4-(Imidazo[1,2-a]pyridin-2-yl)phenoxy]-3-{4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl}propan-2-ol ID: ALA4797980
PubChem CID: 162674732
Max Phase: Preclinical
Molecular Formula: C33H34N4O3
Molecular Weight: 534.66
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2ccccc2N2CCN(C[C@@H](O)COc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1
Standard InChI: InChI=1S/C33H34N4O3/c1-39-28-13-9-25(10-14-28)30-6-2-3-7-32(30)36-20-18-35(19-21-36)22-27(38)24-40-29-15-11-26(12-16-29)31-23-37-17-5-4-8-33(37)34-31/h2-17,23,27,38H,18-22,24H2,1H3/t27-/m1/s1
Standard InChI Key: UMIUFZIZERXHBB-HHHXNRCGSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
11.2577 -8.5062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2565 -9.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9687 -9.7388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6825 -9.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6796 -8.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9669 -8.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9704 -10.5580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2568 -10.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2563 -11.7905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9685 -12.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6828 -11.7872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6799 -10.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9694 -13.0214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6817 -13.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5444 -9.7379 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8328 -9.3287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5437 -10.5592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8316 -10.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1242 -10.5581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4120 -10.9702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1248 -9.7368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7005 -10.5570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9883 -10.9691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2768 -10.5558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5647 -10.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7011 -9.7356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8559 -10.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1442 -10.9633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1431 -11.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8596 -12.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5684 -11.7847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4322 -12.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6841 -11.8640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3430 -13.0128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5450 -13.1874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1351 -12.4778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3169 -12.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9077 -13.1933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3268 -13.9035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1436 -13.8967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
10 13 1 0
13 14 1 0
2 15 1 0
15 16 1 0
15 17 1 0
17 18 1 0
16 21 1 0
18 19 1 0
19 20 1 0
19 21 1 0
20 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
22 26 1 6
25 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 25 1 0
32 33 1 0
33 36 2 0
35 34 1 0
34 32 2 0
29 32 1 0
35 36 1 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 534.66Molecular Weight (Monoisotopic): 534.2631AlogP: 5.24#Rotatable Bonds: 9Polar Surface Area: 62.47Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 7.65CX LogP: 5.25CX LogD: 4.81Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.28Np Likeness Score: -1.37
References 1. Lacivita E,Niso M,Stama ML,Arzuaga A,Altamura C,Costa L,Desaphy JF,Ragozzino ME,Ciranna L,Leopoldo M. (2020) Privileged scaffold-based design to identify a novel drug-like 5-HT receptor-preferring agonist to target Fragile X syndrome., 199 [PMID:32442850 ] [10.1016/j.ejmech.2020.112395 ]